Takeda Pharmaceutical (TKPHF) FCF Payout Ratio (2018 - 2026)

Takeda Pharmaceutical's FCF Payout Ratio history runs 9 years deep, the most recent figure standing at 0.07 for Q1 2026.

• In Q1 2026, FCF Payout Ratio fell 102.24% year-over-year to 0.07; the TTM figure through Mar 2026 stood at 0.26 (down 7.98% YoY), while the FY2026 annual figure was 0.26, down 6.54% from the prior year.
• FCF Payout Ratio was 0.07 for Q1 2026 at Takeda Pharmaceutical, up from 0.36 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 3.38 in Q1 2022 to a low of 1.02 in Q2 2022.
• Historically, FCF Payout Ratio has averaged 0.23 across 5 years, with a median of 0.07 in 2026.
• The sharpest annual moves came in 2023 and 2024: FCF Payout Ratio plunged 128.0% in 2023, then jumped 52.52% in 2024.
• A 5-year view of FCF Payout Ratio shows it stood at 0.31 in 2022, then slumped by 128.0% to 0.71 in 2023, then surged by 52.52% to 0.34 in 2024, then fell by 5.91% to 0.36 in 2025, then jumped by 79.77% to 0.07 in 2026.
• The last three FCF Payout Ratio figures came in at 0.07 (Q1 2026), 0.36 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.